Paper31387239
Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P and 10 others. Int J Mol Sci, 2019. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer. Papers, record 31387239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31387239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Colorectal Neoplasms | Major topic |
| Transcriptome | Major topic |
| Aged | |
| Aged, 80 and over | |
| Combined Modality Therapy | |
| Female | |
| Gene Expression Profiling | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Neoplasm Grading | |
| Neoplasm Metastasis | |
| Neoplasm Staging | |
| Prognosis | |
| Proportional Hazards Models | |
| ROC Curve |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17043639 | Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. | Oncogene | 2007 | https://conductscience.org/library/papers/17043639 | PubMed |
| 2 | 17390049 | A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients. | Oncol Rep | 2007 | https://conductscience.org/library/papers/17390049 | PubMed |
| 3 | 18500245 | Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/18500245 | PubMed |
| 4 | 19508171 | The role of fibroblast growth factors in tumor growth. | Curr Cancer Drug Targets | 2009 | https://conductscience.org/library/papers/19508171 | PubMed |
| 5 | 19556882 | Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescence. | Cell Cycle | 2009 | https://conductscience.org/library/papers/19556882 | PubMed |
| 6 | 20029424 | A census of amplified and overexpressed human cancer genes. | Nat Rev Cancer | 2010 | https://conductscience.org/library/papers/20029424 | PubMed |
| 7 | 20143136 | A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. | Clin Exp Metastasis | 2010 | https://conductscience.org/library/papers/20143136 | PubMed |
| 8 | 20304247 | Colorectal cancer. | Lancet | 2010 | https://conductscience.org/library/papers/20304247 | PubMed |
| 9 | 20679606 | Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20679606 | PubMed |
| 10 | 20817072 | Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia. | Exp Hematol | 2010 | https://conductscience.org/library/papers/20817072 | PubMed |
| 11 | 21098318 | Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21098318 | PubMed |
| 12 | 21304502 | Genetics: an 18-gene signature (ColoPrint®) for colon cancer prognosis. | Nat Rev Clin Oncol | 2011 | https://conductscience.org/library/papers/21304502 | PubMed |
| 13 | 21419747 | The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. | Cell Stem Cell | 2011 | https://conductscience.org/library/papers/21419747 | PubMed |
| 14 | 21472696 | Digital multiplexed gene expression analysis using the NanoString nCounter system. | Curr Protoc Mol Biol | 2011 | https://conductscience.org/library/papers/21472696 | PubMed |
| 15 | 22067406 | Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/22067406 | PubMed |
| 16 | 22208948 | Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. | BMC Cancer | 2011 | https://conductscience.org/library/papers/22208948 | PubMed |
| 17 | 22321063 | Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpnα1 and Kpnβ1. | Traffic | 2012 | https://conductscience.org/library/papers/22321063 | PubMed |
| 18 | 22670670 | Comparative proteomic analysis of colon cancer cell HCT-15 in response to all-trans retinoic acid treatment. | Protein Pept Lett | 2012 | https://conductscience.org/library/papers/22670670 | PubMed |
| 19 | 23474987 | ATPase-dependent quality control of DNA replication origin licensing. | Nature | 2013 | https://conductscience.org/library/papers/23474987 | PubMed |
| 20 | 23550210 | Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. | Sci Signal | 2013 | https://conductscience.org/library/papers/23550210 | PubMed |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42287015 | The Importance of 14-3-3 Proteins in Colorectal Cancer Regulation: Mechanisms of Function and Clinical Opportunities. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42287015 | PubMed |
| 42248826 | The CDK4/6 inhibitor dalpiciclib augments the antitumor efficacy of enzalutamide in preclinical models of castration-resistant prostate cancer through inhibition of MCM4-mediated DNA replication. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42248826 | PubMed |
| 41191200 | Prognostic significance of dipeptidyl peptidase-7 (DPP7) in HPV16-negative head and neck squamous cell carcinoma treated with induction chemoradiotherapy. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41191200 | PubMed |
| 40950355 | Colorectal cancer prognosis: insights from the tumor immune microenvironment and gut microbiota. | J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/40950355 | PubMed |
| 40682849 | Chromosome 20q gene signature associated with colorectal cancer progression. | Oncol Rep | 2025 | https://conductscience.org/library/papers/40682849 | PubMed |
| 40564876 | MCM4 as Potential Metastatic Biomarker in Lung Adenocarcinoma. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40564876 | PubMed |
| 40216815 | Integrated single cell and bulk RNA sequencing analyses reveal the impact of tryptophan metabolism on prognosis and immunotherapy in colon cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40216815 | PubMed |
| 40064736 | ZNF385A was identified as a novel colorectal cancer-related functional gene by analysis of the interaction and immune characteristics of oxidative stress and the inflammatory response. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40064736 | PubMed |
| 39999107 | FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway. | PLoS One | 2025 | https://conductscience.org/library/papers/39999107 | PubMed |
| 39886381 | Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/39886381 | PubMed |
| 39754775 | PPA1, TRIM68 and FBXO46: Potential Therapeutic Targets for Triple Negative Breast Cancer. | Curr Protein Pept Sci | 2025 | https://conductscience.org/library/papers/39754775 | PubMed |
| 39335194 | The 3-Biomarker Classifier-A Novel and Simple Molecular Risk Score Predicting Overall Survival in Patients with Colorectal Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39335194 | PubMed |
| 39247602 | DPP7 as a Potential Therapeutic Marker for Colorectal Cancer. | J Cancer | 2024 | https://conductscience.org/library/papers/39247602 | PubMed |
| 38975206 | Integrative analyses of multi-omics data constructing tumor microenvironment and immune-related molecular prognosis model in human colorectal cancer. | Heliyon | 2024 | https://conductscience.org/library/papers/38975206 | PubMed |
| 38732562 | Iron Supplementation Increases Tumor Burden and Alters Protein Expression in a Mouse Model of Human Intestinal Cancer. | Nutrients | 2024 | https://conductscience.org/library/papers/38732562 | PubMed |
| 38356712 | Identification of novel T cell proliferation patterns, potential biomarkers and therapeutic drugs in colorectal cancer. | J Cancer | 2024 | https://conductscience.org/library/papers/38356712 | PubMed |
| 38054820 | Integrating scRNA-seq and bulk RNA-seq to characterize infiltrating cells in the colorectal cancer tumor microenvironment and construct molecular risk models. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/38054820 | PubMed |
| 38026928 | Natural killer cell-related prognosis signature predicts immune response in colon cancer patients. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38026928 | PubMed |
| 37568770 | Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37568770 | PubMed |
| 37377935 | Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37377935 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31387239
GET https://conductscience.org/api/papers/v1/31387239/references?page=2